Callithrix penicillata: A feasible experimental model for dengue virus infection

Immunology Letters

Volumn 158, Issue 1-2, 2014, Pages 126-133

  Ferreira, Milene Silveira ^a,b   de Castro, Paulo Henrique Gomes ^c   Silva, Gilmara Abreu ^c   Casseb, Samir Mansur Moraes ^a   Dias Júnior, AntÔnio Gregório ^a   Rodrigues, Sueli Guerreiros ^a   Azevedo, Raimunda do Socorro da Silva ^a   Silva, Matheus Fernandes Costa e ^d   Zauli, Danielle Alves Gomes ^d   Araújo, Márcio Sobreira Silva ^d   Béla, Samantha Ribeiro ^d   Teixeira Carvalho, Andréa ^d   Martins Filho, Olindo Assis ^d   Vasconcelos, Pedro Fernando da Costa ^a,e  

^a INSTITUTO EVANDRO CHAGAS   (Brazil)

^b FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^c Centro Nacional de Primatas   (Brazil)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

^e UNIVERSIDADE DO ESTADO DO PARÁ   (Brazil)

Author keywords

Dengue virus infection; Experimental model; Immune response; Non human; Primate

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CREATININE; GAMMA INTERFERON; HEMOGLOBIN; INTERLEUKIN 2; INTERLEUKIN 5; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; UREA; AMINOTRANSFERASE; CYTOKINE; IMMUNOGLOBULIN M; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALLITHRIX; CALLITHRIX PENICILLATA; CONTROLLED STUDY; DENGUE; DENGUE VIRUS 3; ERYTHROCYTE COUNT; EXPERIMENTAL MODEL; FEASIBILITY STUDY; FUNCTIONAL ASSESSMENT; HEMAGGLUTINATION INHIBITION TEST; HEMATOCRIT; IMMUNE RESPONSE; KIDNEY FUNCTION; LEUKOPENIA; LIVER FUNCTION; LYMPHOCYTE COUNT; LYMPHOCYTOSIS; MONOCYTE; MONOCYTOSIS; NEUTROPHIL COUNT; NEUTROPHILIA; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; VIRUS IDENTIFICATION; VIRUS LOAD; ANEMIA; ANIMAL; BLOOD; BLOOD CLOTTING; CELL COUNT; COMPLICATION; DENGUE VIRUS; DISEASE MODEL; IMMUNOLOGY;

ANEMIA; ANIMALS; ANTIBODIES, VIRAL; BIOLOGICAL MARKERS; BLOOD COAGULATION; CALLITHRIX; CELL COUNT; CREATININE; CYTOKINES; DENGUE; DENGUE VIRUS; DISEASE MODELS, ANIMAL; FEASIBILITY STUDIES; IMMUNOGLOBULIN M; LEUKOPENIA; THROMBOCYTOPENIA; TRANSAMINASES; VIRAL LOAD;

EID: 84892467728     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2013.12.008     Document Type: Article

References (32)

1. Herrero L.J., Zakhary A., Gahan M.E., Nelson M.A., Herring B.L., Hapel A.J., et al. Dengue virus therapeutic intervention strategies based on viral, vector and host factors involved in disease pathogenesis. Pharmacol Ther 2013, 137:266-282.
2. Gonçalves D., de Queiroz Prado R., Almeida Xavier E., Cristina de Oliveira N., da Matta Guedes P.M., da Silva J.S., et al. Imunocompetent mice model for dengue virus infection. SciWorld J 2012, 2012:1-12.
3. Yacoub S., Mongkolsapaya J., Screaton G. The pathogenesis of dengue. Curr Opin Infect Dis 2013, 29:7221-7228.
4. Bhatt S., Gething P.W., Brady O.J., Messina J.P., Farlow A.W., Moyes C.L., et al. The global distribution and burden of dengue. Nature 2013, 25:504-507.
5. Gubler D.J. Dengue and dengue hemorrhagic fever: its history and resurgence as a global public health problem. Dengue and dengue hemorrhagic fever 1997, Cab International, London. D.J. Gubler, G. Kuno (Eds.).
6. Murray P.R., Rosenthal K.S., Kobayashi G.S., Pfaller M.A. Microbiologia médica 2000, Guanabara Koogan, Rio de Janeiro. 4th ed.
7. Guzman M.G., Alvarez M., Halstead S.B. Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. Arch Virol 2013, 1-15.
8. BRASIL Ministério da Saúde Guia de vigilância epidemiológica 2002, Fundação Nacional de Saúde, Brasília.
9. Chen W.F., Yeh W.T., Yang M.Y. A model of the real-time correlation of viral titers with immune reactions in antibody-dependent enhancement of dengue-2 infection. FEMS Immunol Med Microbiol 2001, 30:1-7.
10. Kuruvilla J.G., Troyer R.M., Devi S., Akkina R. Dengue virus infection and immune response in humanized RAG2(-/-)gamma(c)(-/-) (RAG-hu) mice. Virology 2007, 369:143-152.
11. Diniz D.G., Foro C.A.R., Turiel M.C.P., Sostenes M.C.K., Demacki S., Gomes G.F., et al. Environmental influences on antibody-enhanced dengue disease outcomes. Mem Inst Oswaldo Cruz 2012, 107:1021-1029.
12. Blaney J.E., Matro J.M., Murphy B.R., Whitehead S.S. Recombinant, live attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys. J Virol 2005, 79:5516-5528.
13. Sun W., Nisalak A., Gettayacamin M., Eckels K.H., Putnak J.R. Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination. J Infect Dis 2006, 193:1658-1665.
14. Onlamoon N., Noisakran S., Hsiao H.M., Duncan A., Villinger F., Ansari A.A., et al. Dengue virus induced hemorrhage in a nonhuman primate model. Blood 2010, 4:1823-1834.
15. Ito M., Mukai R.Z., Takasaki T., Kotaki A., Kurane I. Antibody-dependent enhancement of dengue virus infection in vitro by undiluted sera from monkeys infected with heterotypic dengue virus. Arch Virol 2010, 155:1617-1624.
16. Omatsu T., Moi M.L., Hirayama T., Takasaki T., Nakamura S., Tajima S., et al. Common marmoset (Callithrix jacchus) as a primate model of dengue virus infection: development of high levels of viraemia and demonstration of protective immunity. J Gen Virol 2011, 92:2272-2280.
17. Omatsu T., Moi M.L., Takasaki T., Nakamura S., Katakai Y., Tajima S., et al. Changes in hematological and serum biochemical parameters in common marmosets (Callithrix jacchus) after inoculation with dengue virus. J Med Primatol 2012, 41:289-296.
18. Yoshida T., Omatsu T., Saito A., Katakai Y., Iwasaki Y., Kurosawa T., et al. Dynamics of cellular immune responses in the acute phase of dengue virus infection. Arch Virol 2013, 158:1209-1220.
19. Igarashi A. Isolation of a Singli' Aedes albopictus cell clone sensitive to dengue and chikungunya viruses. J Gen Virol 1978, 40:531-544.
20. Gubler D.J., Kuno G., Sather G.E. Mosquito cell cultures and specific monoclonal antibodies in surveillance for dengue viruses. Am J Trop Med Hyg 1984, 33:158-165.
21. Malewiczt B., Jenkin H.M. Development of dengue virus plaques under serum-free overlay medium. J Clin Microbiol 1979, 60:9-14.
22. Johnson B.W., Russell B.J., Lanciotti R.S. Serotype-specific detection of dengue viruses in a fourplex real-time reverse transcriptase PCR assay. J Clin Microbiol 2005, 43:4977-4983.
23. Sambrook J., Russell D.W. Molecular cloning: a laboratory manual 2001, Cold Spring Harbor, New York. 4th ed.
24. Kuno G., Gómez I., Gubler D.J. Detecting artificial anti-dengue IgM immune complexes using an enzyme-linked immunosorbent assay. Am J Trop Med Hyg 1987, 36:153-159.
25. Clarke D.H., Casals J. Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. Am J Trop Med Hyg 1958, 7:561-573.
26. Shope R.E. The use of a microhemagglutination-inhibition test to follow antibody response after arthropod-borne virus infection in a community of forest animals. Anais de Microbiologia 1963, 11:167-171.
27. Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003, 13:2498-2504.
28. Costa V.V., Fagundes C.T., da Glória de Souza D., Teixeira M.M. Inflammatory and innate immune responses in dengue infection: protection versus disease induction. Am J Pathol 2013, 6:1-7.
29. Zompi S., Harris E. Animal models of dengue virus infection. Viruses 2012, 4:62-82.
30. Cruz A.C.R., Prazeres A.S.C., Gama E.C., Lima M.F., Azevedo R.S.S., Casseb L.M.N., et al. Vigilância Sorológica para Arbovírus em Juruti, Pará, Brasil. Cadernos de Saúde Pública (ENSP Impress) 2009, 25:1153-1159.
31. Simmons D., Jeremy C.P., Farrar J., Nguyen Van Vinh Chau D., Bridget Wills D.M. Dengue. N Engl J Med 2012, 15:135-147.
32. Taylor R. Interpretation of the correlation coefficient: a basic review. J Diag Med Sonogr 1990, 1:35-39.